Area of research
Cardiology and Cardiovascular Medicine · Hematology
Research interest
Research interests include Cardiac pacing and defibrillation studies, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, and Iron Metabolism and Disorders.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial
Dyskalemia in People at Increased Risk for Heart Failure: Findings from the Heart ‘OMics’ in AGEing (HOMAGE) Trial
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
Effects of Spironolactone on Serum Markers of Fibrosis in People at High Risk of Developing Heart Failure: Rationale, Design and Baseline Characteristics of a Proof-of-Concept, Randomised, Precision-Medicine, Prevention Trial. The Heart OMics in AGing (HOMAGE) Trial